Vikas Agarwal

Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment

Narendra N. Khanna, Mahesh Maindarkar, Vijay Viswanathan et al. · Healthcare · 2022 · 324 citations · Full text

Health Professions, Health Informatics, Pharmacoeconomics +16

Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel®): preclinical and clinical trial in osteoarthritis of the knee joint

Pawan Kumar Gupta, Anoop Chullikana, Mathiyazhagan Rengasamy et al. · Arthritis Research & Therapy · 2016 · 322 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial

Arvinder S. Soin, Kuldeep Kumar, Narendra S. Choudhary et al. · The Lancet Respiratory Medicine · 2021 · 237 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial

Padmanabha Shenoy, Sudeep Kumar, L. K. Jha et al. · Lara D. Veeken · 2010 · 184 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +14

Information and Misinformation on COVID-19: a Cross-Sectional Survey Study

Latika Gupta, Armen Yuri Gasparyan, Durga Prasanna Misra et al. · Journal of Korean Medical Science · 2020 · 178 citations · Full text

Social Sciences, Infectious Diseases, Epidemiology +14